Latest Noonan Syndrome Stories
Scientists at USC have unlocked the mystery of why new cases of the genetic disease Noonan Syndrome are so common: a mutation that causes the disease disproportionately increases a normal father’s production of sperm carrying the disease trait.
Congenital heart diseases affect approximately one in 100 patients, making them the most common type of birth defect and the number-one cause of pediatric deaths.
Noonan syndrome is a relatively common genetic disorder characterized by short stature, unique facial features, and heart defects.
PRINCETON, N.J., March 3 /PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved NorditropinÂ® FlexProÂ® (somatropin [rDNA origin] injection), a pre-filled injection pen to be used by children and adults with growth hormone disorders.
Discovery could lead to treatments for learning and memory deficits, particularly Noonan's syndrome.